Home | HR Pulse Daily » News » COVID-19: What You Need to Know About the Coronavirus Epidemic That Began on December 8th

COVID-19: What You Need to Know About the Coronavirus Epidemic That Began on December 8th

Globalization and world trade bounce back from the impact of COVID-19: report

 

Have you read?

  • Globalization and world trade bounce back from the impact of COVID-19: report
  • This is how COVID-19 hit household expenditure in Europe
  • COVID-19 is still causing parental burnout – do you know the symptoms?

Britain is marking a year since the first person in the world was given a Pfizer-BioNTech COVID-19 vaccine outside of clinical trials. On 8 December, 2020, Margaret Keenan, a 90-year-old grandmother, became the first person to get the shot following its clinical approval. Britain has now given nearly 120 million doses of COVID-19 vaccine, either as first doses, second doses or as boosters.

A rebound in market sentiment continued in early European trading on Wednesday, with world shares set for their biggest two-day jump since November last year as investors became less concerned about the Omicron variant. Shares plunged recently when the discovery of the new COVID-19 variant spooked investors. But sentiment has rebounded sharply this week in the absence of indications that Omicron would derail the economic recovery.

Have you read?

  • Globalization and world trade bounce back from the impact of COVID-19: report
  • This is how COVID-19 hit household expenditure in Europe
  • COVID-19 is still causing parental burnout – do you know the symptoms?

Britain is marking a year since the first person in the world was given a Pfizer-BioNTech COVID-19 vaccine outside of clinical trials. On 8 December, 2020, Margaret Keenan, a 90-year-old grandmother, became the first person to get the shot following its clinical approval. Britain has now given nearly 120 million doses of COVID-19 vaccine, either as first doses, second doses or as boosters.

A rebound in market sentiment continued in early European trading on Wednesday, with world shares set for their biggest two-day jump since November last year as investors became less concerned about the Omicron variant. Shares plunged recently when the discovery of the new COVID-19 variant spooked investors. But sentiment has rebounded sharply this week in the absence of indications that Omicron would derail the economic recovery.

. More than 8.28 billion vaccination doses have been administered globally, according to Our World in Data.

Americans are lining up for booster doses of COVID-19 vaccines at a record pace, with concerns about the newly detected Omicron coronavirus variant spurring millions to get shots, the US government said on Tuesday. Just under a million people a day received booster doses of one of the three authorized vaccines last week, the highest rate since US regulators gave the nod to additional shots for some adults in September, government data shows.

Germany recorded the highest number of deaths from COVID-19 since February on Wednesday as it battles to stop a fourth wave of the pandemic. A total of 69,601 new infections were reported, 2,415 more than the same time a week ago, and another 527 people died – the highest number since 12 February – to bring the total to 104,047, the Robert Koch Institute for disease control said.

South Korea will consider expanding home treatment of COVID-19 patients, a health official said on Wednesday, as both new daily infections and severe cases hit record highs, putting hospital capacity under strain. Infections in South Korea have skyrocketed this month after the government began to ease restrictions. The Korea Disease Control and Prevention Agency reported 7,175 new coronavirus cases and 63 deaths for Tuesday, the first time daily infections have topped 7,000.

The African Union (AU) has called for an urgent end to travel restrictions imposed on some of its member states, saying the measures effectively penalize governments for timely data sharing in line with international health regulations. The measures act “as a disincentive for information sharing in the future”, the AU said in a statement. Late last month several countries imposed travel curbs on seven southern African nations after they reported cases of the Omicron variant.

Have you read

  • Globalization and world trade bounce back from the impact of COVID-19: report
  • This is how COVID-19 hit household expenditure in Europe
  • COVID-19 is still causing parental burnout – do you know the symptoms?

Britain is marking a year since the first person in the world was given a Pfizer-BioNTech COVID-19 vaccine outside of clinical trials. On 8 December, 2020, Margaret Keenan, a 90-year-old grandmother, became the first person to get the shot following its clinical approval. Britain has now given nearly 120 million doses of COVID-19 vaccine, either as first doses, second doses or as boosters.

A rebound in market sentiment continued in early European trading on Wednesday, with world shares set for their biggest two-day jump since November last year as investors became less concerned about the Omicron variant. Shares plunged recently when the discovery of the new COVID-19 variant spooked investors. But sentiment has rebounded sharply this week in the absence of indications that Omicron would derail the economic recovery.

About the author

Rajesh Tamada